82 results
Page 3 of 5
8-K
EX-99.2
cwuv kden
6 Jul 20
Our mission is to create a world without infectious disease
6:32am
DRS
EX-10.21
ufqw bpqcc51wq2z
23 Jun 20
Draft registration statement
12:00am
DRS
EX-10.56
7anndfxt jku
23 Jun 20
Draft registration statement
12:00am
8-K
EX-99.1
d8tp hkt1s4yef1tpdk1
29 May 20
Vir Biotechnology and Biogen Execute Agreement to ManufactureSARS-CoV-2 Antibodies for PotentialCOVID-19 Treatment
4:06pm
8-K
EX-99.1
yad1k9phb 90rnks
10 Apr 20
Samsung Biologics and Vir Biotechnology Enter into Agreement for Large Scale Manufacture ofSARS-COV-2 Antibodies for Potential COVID-19 Treatment
8:01am
DEF 14A
1irw 61mb
6 Apr 20
Definitive proxy
4:52pm
10-K
EX-10.19
0vfkxb9s oi6si
26 Mar 20
Annual report
4:08pm
10-K
fgguyz bduf8mx05tgkc
26 Mar 20
Annual report
4:08pm
10-K
EX-10.20
8qm ehbdqsshp
26 Mar 20
Annual report
4:08pm
10-K
EX-10.22
4mjsgu96k qczowlwak
26 Mar 20
Annual report
4:08pm
10-Q
wx4jyj
19 Nov 19
Quarterly report
4:06pm
S-8
EX-4.8
l2bl3doy
15 Oct 19
Registration of securities for employees
4:47pm
424B4
q9x7ts4blc9lta
11 Oct 19
Prospectus supplement with pricing info
5:31pm
S-1/A
EX-10.2
irgtpy45enc2mysbmnv
30 Sep 19
IPO registration (amended)
6:12am
S-1/A
EX-3.1
vc3 w2taac
30 Sep 19
IPO registration (amended)
6:12am
S-1/A
zzpsnnji0etb
30 Sep 19
IPO registration (amended)
6:12am
S-1
EX-10.18
ollsb 2oi4ix6c5atfk
3 Sep 19
IPO registration
4:40pm
S-1
EX-10.25
ei57w 9xuxoeanqy
3 Sep 19
IPO registration
4:40pm
S-1
EX-10.27
ly5nn6s3
3 Sep 19
IPO registration
4:40pm